Mortality risk with the use of atypical antipsychotics in later-life bipolar disorder

Sachin Bhalerao, Lisa S. Seyfried, Hyungjin Myra Kim, Claire Chiang, Janet Kavanagh, Helen C. Kales

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Introduction: In recent years, concerns about the use of antipsychotic medications in dementia have grown. There is limited data on mortality risk of atypical antipsychotics for other psychiatric disorders of later life such as bipolar disorder. Methods: Data were derived from the national Department of Veterans Affairs registries for older patients with bipolar disorder (>65 years) with a new start of an atypical antipsychotic (risperidone, olanzapine, or quetiapine) or valproic acid and derivatives during fiscal years 2001-2008. Six-month mortality rates were compared for individual drug groups. Results: The sample included 4717 patients. The risperidone cohort had the highest mortality rate (11.8 per 100 person-years) with the quetiapine and valproic acid cohorts having the lowest (5.3 and 4.6 per 100 person-years, respectively). Various methods to adjust for baseline differences including propensity models showed similar patterns. Conclusions: Among older patients with bipolar disorder, there may be differences in mortality risks among individual antipsychotic agents.

Original languageEnglish (US)
Pages (from-to)29-36
Number of pages8
JournalJournal of Geriatric Psychiatry and Neurology
Volume25
Issue number1
DOIs
StatePublished - Mar 1 2012
Externally publishedYes

Fingerprint

Bipolar Disorder
Antipsychotic Agents
Risperidone
Mortality
Valproic Acid
olanzapine
Veterans
Psychiatry
Dementia
Registries
Pharmaceutical Preparations
Quetiapine Fumarate

Keywords

  • antipsychotics
  • bipolar disorder
  • geriatric

ASJC Scopus subject areas

  • Clinical Neurology
  • Geriatrics and Gerontology
  • Psychiatry and Mental health

Cite this

Mortality risk with the use of atypical antipsychotics in later-life bipolar disorder. / Bhalerao, Sachin; Seyfried, Lisa S.; Kim, Hyungjin Myra; Chiang, Claire; Kavanagh, Janet; Kales, Helen C.

In: Journal of Geriatric Psychiatry and Neurology, Vol. 25, No. 1, 01.03.2012, p. 29-36.

Research output: Contribution to journalArticle

Bhalerao, Sachin ; Seyfried, Lisa S. ; Kim, Hyungjin Myra ; Chiang, Claire ; Kavanagh, Janet ; Kales, Helen C. / Mortality risk with the use of atypical antipsychotics in later-life bipolar disorder. In: Journal of Geriatric Psychiatry and Neurology. 2012 ; Vol. 25, No. 1. pp. 29-36.
@article{1d627efe2a0b461d89d5abc9d04ed32d,
title = "Mortality risk with the use of atypical antipsychotics in later-life bipolar disorder",
abstract = "Introduction: In recent years, concerns about the use of antipsychotic medications in dementia have grown. There is limited data on mortality risk of atypical antipsychotics for other psychiatric disorders of later life such as bipolar disorder. Methods: Data were derived from the national Department of Veterans Affairs registries for older patients with bipolar disorder (>65 years) with a new start of an atypical antipsychotic (risperidone, olanzapine, or quetiapine) or valproic acid and derivatives during fiscal years 2001-2008. Six-month mortality rates were compared for individual drug groups. Results: The sample included 4717 patients. The risperidone cohort had the highest mortality rate (11.8 per 100 person-years) with the quetiapine and valproic acid cohorts having the lowest (5.3 and 4.6 per 100 person-years, respectively). Various methods to adjust for baseline differences including propensity models showed similar patterns. Conclusions: Among older patients with bipolar disorder, there may be differences in mortality risks among individual antipsychotic agents.",
keywords = "antipsychotics, bipolar disorder, geriatric",
author = "Sachin Bhalerao and Seyfried, {Lisa S.} and Kim, {Hyungjin Myra} and Claire Chiang and Janet Kavanagh and Kales, {Helen C.}",
year = "2012",
month = "3",
day = "1",
doi = "10.1177/0891988712436687",
language = "English (US)",
volume = "25",
pages = "29--36",
journal = "Journal of Geriatric Psychiatry and Neurology",
issn = "0891-9887",
publisher = "SAGE Publications Inc.",
number = "1",

}

TY - JOUR

T1 - Mortality risk with the use of atypical antipsychotics in later-life bipolar disorder

AU - Bhalerao, Sachin

AU - Seyfried, Lisa S.

AU - Kim, Hyungjin Myra

AU - Chiang, Claire

AU - Kavanagh, Janet

AU - Kales, Helen C.

PY - 2012/3/1

Y1 - 2012/3/1

N2 - Introduction: In recent years, concerns about the use of antipsychotic medications in dementia have grown. There is limited data on mortality risk of atypical antipsychotics for other psychiatric disorders of later life such as bipolar disorder. Methods: Data were derived from the national Department of Veterans Affairs registries for older patients with bipolar disorder (>65 years) with a new start of an atypical antipsychotic (risperidone, olanzapine, or quetiapine) or valproic acid and derivatives during fiscal years 2001-2008. Six-month mortality rates were compared for individual drug groups. Results: The sample included 4717 patients. The risperidone cohort had the highest mortality rate (11.8 per 100 person-years) with the quetiapine and valproic acid cohorts having the lowest (5.3 and 4.6 per 100 person-years, respectively). Various methods to adjust for baseline differences including propensity models showed similar patterns. Conclusions: Among older patients with bipolar disorder, there may be differences in mortality risks among individual antipsychotic agents.

AB - Introduction: In recent years, concerns about the use of antipsychotic medications in dementia have grown. There is limited data on mortality risk of atypical antipsychotics for other psychiatric disorders of later life such as bipolar disorder. Methods: Data were derived from the national Department of Veterans Affairs registries for older patients with bipolar disorder (>65 years) with a new start of an atypical antipsychotic (risperidone, olanzapine, or quetiapine) or valproic acid and derivatives during fiscal years 2001-2008. Six-month mortality rates were compared for individual drug groups. Results: The sample included 4717 patients. The risperidone cohort had the highest mortality rate (11.8 per 100 person-years) with the quetiapine and valproic acid cohorts having the lowest (5.3 and 4.6 per 100 person-years, respectively). Various methods to adjust for baseline differences including propensity models showed similar patterns. Conclusions: Among older patients with bipolar disorder, there may be differences in mortality risks among individual antipsychotic agents.

KW - antipsychotics

KW - bipolar disorder

KW - geriatric

UR - http://www.scopus.com/inward/record.url?scp=84859373017&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859373017&partnerID=8YFLogxK

U2 - 10.1177/0891988712436687

DO - 10.1177/0891988712436687

M3 - Article

C2 - 22467844

AN - SCOPUS:84859373017

VL - 25

SP - 29

EP - 36

JO - Journal of Geriatric Psychiatry and Neurology

JF - Journal of Geriatric Psychiatry and Neurology

SN - 0891-9887

IS - 1

ER -